Choose the stock you wish to monitor with a price target
Recently viewedPrice
↑↓ to move↵ to choose
Back to Note
Company Overview
Business Description
Sector
Health Care
Industry
Health Care
Headquarters
United States of AmericaUS
Employees
56 000
IPO date
Mar 17, 1980
Stryker makes medical devices and hospital equipment that help doctors treat injuries, replace damaged joints, and perform surgery. Its products include hip and knee implants, surgical tools, operating-room systems, trauma devices, and equipment used in emergency rooms and ambulances. It also sells products for neurovascular care, which are used in treating certain stroke and brain conditions.
The company sells mainly to hospitals, surgery centers, and other healthcare providers. It earns money by selling devices and equipment upfront and, in some cases, by selling related consumables and replacement parts that are used during procedures. Its customers buy Stryker products because they sit in the middle of the care process: they help surgeons do the operation, help clinicians move patients, and support recovery after treatment.
What makes Stryker's business model different is that it sits inside the medical workflow rather than at the patient-facing end of care. Many of its products are used every day in high-stakes settings, which makes performance, reliability, and training important. That gives Stryker a strong role in hospitals as a supplier of specialized tools that are hard to replace quickly.
This business makes implants and tools used in hip, knee, and other joint replacement and trauma surgery.
Customers and revenue model
MedSurg and Neurotechnology
This business supplies operating room equipment, patient handling products, endoscopy tools, and devices used in neurosurgery and spine-related care.
Customers and revenue model
Spine
Description, customers and revenue model
Management
Mr. Kevin A. Lobo
Chairman, CEO & President
Kevin A. Lobo is a prominent business executive known for his role as Chairman and CEO of Stryker Corporation, a leading global medical technology company. He joined Stryker in 2011 as Group President of Orthopaedics, and shortly after, in October 2012, he was appointed President and CEO. Under his leadership, Stryker has expanded its global reach and product offerings, maintaining a strong presence in the medical technology industry.
Lobo has been instrumental in guiding the company's strategic acquisitions and innovations, focusing on diversifying its product portfolio and enhancing operational efficiencies. Before joining Stryker, Lobo held senior leadership roles at Johnson & Johnson, where he gained extensive experience in finance, operations, and management. He has a background in finance and accounting, holding a bachelor's degree in Commerce from McGill University and an MBA from the University of Toronto. His leadership style is characterized by a strong commitment to strategic growth, sustainability, and ethical business practices.
Mr. Glenn S. Boehnlein CPA
VP & CFO
Glenn S. Boehnlein is the Vice President, Chief Financial Officer (CFO), and Secretary of Stryker Corporation, a leading global medical technology company. He has been with Stryker since 2003, initially joining as the Vice President of Finance and Corporate Controller. In 2016, he was appointed CFO, where he oversees the company's financial operations, including accounting, budgeting, and financial planning. Boehnlein holds a Bachelor of Business Administration in Accounting from the University of Notre Dame and a Master of Business Administration from the University of Chicago Booth School of Business. His leadership in financial strategy has been pivotal in Stryker's growth and success in the medical technology industry.
Mr. Viju S. Menon
Group President of Global Quality & Operations
Viju S. Menon is a well-known executive associated with Stryker Corporation, a leading medical technologies firm. As a prominent leader within the company, he has held significant roles that have contributed to the company's growth and innovation. Menon joined Stryker bringing with him a wealth of experience from various industries. His expertise spans operations management, process optimization, and strategic development. At Stryker, he has been instrumental in enhancing the company’s operational efficiencies, supply chain management, and overall business strategies. His leadership style is often characterized by a strong focus on fostering innovation, improving customer satisfaction, and driving sustainable growth. Menon's contributions have been vital in maintaining Stryker's position as a leader in the medical technology sector.
Mr. J. Andrew Pierce
Group President of MedSurg & Neurotechnology
J. Andrew Pierce is a notable figure associated with Stryker Corporation, a leading medical technology company. As of the latest information available, he serves as the Group President of MedSurg and Neurotechnology at Stryker. In this capacity, he oversees Stryker's operations related to its MedSurg and Neurotechnology business segments, focusing on driving innovation and growth within these areas.
Pierce joined Stryker in 1990 and has held various leadership roles throughout his career, demonstrating strong expertise and a significant impact on the company's development. His leadership skills and strategic vision have been instrumental in expanding Stryker's market presence and enhancing its product offerings.
Under his guidance, the MedSurg and Neurotechnology divisions have achieved substantial progress, contributing to Stryker's overall success as a prominent player in the medical technology industry. Pierce’s commitment to innovation, quality, and customer satisfaction underscores his effectiveness as a leader at Stryker.
Mr. Spencer S. Stiles
Group President of Orthopaedics & Spine
Spencer S. Stiles is an executive at Stryker Corp., a leading medical technologies firm. He has held various leadership roles within the company. Currently, he serves as the Group President of Orthopaedics and Spine, overseeing the strategic direction and operation of these divisions. Stiles joined Stryker in 1996 and has held numerous positions, gaining extensive experience across different business units. His leadership has been instrumental in driving growth and innovation within the organization. Stiles is known for his strong focus on operational excellence and delivering value to both the company and its customers.
Mr. William E. Berry Jr.
VP & Chief Accounting Officer
William E. Berry Jr. is a well-regarded business executive who served as the Vice President, Corporate Secretary, and Chief Legal Officer of Stryker Corporation. In his role at Stryker, a leading medical technologies firm, Berry was responsible for overseeing the legal affairs of the company, including corporate governance and compliance matters. His expertise in legal management and dedication to ensuring ethical practices were key in maintaining Stryker’s reputable standing in the healthcare sector.
Berry's extensive legal background, combined with his experience in corporate governance, positioned him as a valuable leader within the company. His work contributed significantly to navigating the complex regulatory environment of the medical device industry. Berry's leadership and strategic insight were instrumental in steering the company's growth and success in deploying advanced medical technologies worldwide.
Mr. Robert C. Cohen
CTO and VP of Global R&D - Joint Replacement
Robert C. Cohen is a prominent executive known for his leadership at Stryker Corporation, a global leader in medical technology. At Stryker, he has held significant roles, especially within the company's Orthopaedics division. As President of Stryker's Digital, Robotics, and Enabling Technologies group, Cohen played a key role in advancing the company's innovative solutions, focusing on robotics and digital advancements that align with the future of orthopedic surgeries.
Under his leadership, Stryker has seen developments in robotic-assisted surgery with their Mako system, as well as other digital technology mergers that have bolstered the company's presence in the medical tech industry. Robert Cohen is recognized for his capacity to drive growth, his strategic vision, and his commitment to improving patient outcomes through cutting-edge technology. His deep industry experience and forward-thinking approach continue to propel Stryker's mission of making healthcare better.
Mr. Alan Douville
VP, Chief Information Officer & Chief Information Security Officer
As of the last available information, Alan Douville served as an executive at Stryker Corporation. Stryker is a well-known medical technologies firm, and executives play crucial roles in overseeing its operations and strategic direction. Their leadership is essential in shaping the company's innovations in medical devices and equipment, which contributes to advancements in healthcare. However, specific details about Alan Douville’s role, accomplishments, or biography at Stryker Corp are not readily available publicly. Therefore, detailed personal or career-related information about him might be limited to internal company resources or private documents. If you are seeking specific details, it would be beneficial to consult Stryker's official resources or press releases.
Mr. Jason Beach
Vice President of Finance & Investor Relations
Jason Beach is not widely recognized in public directories or notable executive profiles associated with Stryker Corporation, a prominent medical technology company. Without specific information or verified sources, it is challenging to provide a detailed biography for an executive by that name from Stryker Corp. If you have more context or specific details about his role or contributions, it might help refine the search. Otherwise, based on the available data, I would conclude "FALSE" regarding any widely acknowledged biography of Jason Beach at Stryker Corporation.
Mr. Robert S. Fletcher
VP & Chief Legal Officer
Robert S. Fletcher is an executive known for his leadership role at Stryker Corporation, a leading medical technologies firm. At Stryker, Fletcher has been instrumental in driving the company's strategic initiatives, focusing on innovation and growth across its diverse product lines. Under his leadership, Stryker has advanced in areas such as orthopedics, medical and surgical equipment, and neurotechnology.
Fletcher has a strong background in the healthcare and medical devices industry, bringing with him a wealth of experience that supports the company's mission to make health care better. He is recognized for his ability to align Stryker's operations with global health care demands, ensuring the organization remains at the forefront of technological advancement and patient care enhancement.
His tenure at Stryker is marked by a commitment to quality and a forward-thinking approach to addressing the needs of health care professionals and patients worldwide. Through fostering innovation, improving operational efficiencies, and managing a dynamic portfolio, Fletcher continues to contribute significantly to Stryker’s prominence in the global market.
1 / 10
Mr. Kevin A. Lobo
Chairman, CEO & President
Kevin A. Lobo is a prominent business executive known for his role as Chairman and CEO of Stryker Corporation, a leading global medical technology company. He joined Stryker in 2011 as Group President of Orthopaedics, and shortly after, in October 2012, he was appointed President and CEO. Under his leadership, Stryker has expanded its global reach and product offerings, maintaining a strong presence in the medical technology industry.
Lobo has been instrumental in guiding the company's strategic acquisitions and innovations, focusing on diversifying its product portfolio and enhancing operational efficiencies. Before joining Stryker, Lobo held senior leadership roles at Johnson & Johnson, where he gained extensive experience in finance, operations, and management. He has a background in finance and accounting, holding a bachelor's degree in Commerce from McGill University and an MBA from the University of Toronto. His leadership style is characterized by a strong commitment to strategic growth, sustainability, and ethical business practices.
Mr. Glenn S. Boehnlein CPA
VP & CFO
Glenn S. Boehnlein is the Vice President, Chief Financial Officer (CFO), and Secretary of Stryker Corporation, a leading global medical technology company. He has been with Stryker since 2003, initially joining as the Vice President of Finance and Corporate Controller. In 2016, he was appointed CFO, where he oversees the company's financial operations, including accounting, budgeting, and financial planning. Boehnlein holds a Bachelor of Business Administration in Accounting from the University of Notre Dame and a Master of Business Administration from the University of Chicago Booth School of Business. His leadership in financial strategy has been pivotal in Stryker's growth and success in the medical technology industry.
Mr. Viju S. Menon
Group President of Global Quality & Operations
Viju S. Menon is a well-known executive associated with Stryker Corporation, a leading medical technologies firm. As a prominent leader within the company, he has held significant roles that have contributed to the company's growth and innovation. Menon joined Stryker bringing with him a wealth of experience from various industries. His expertise spans operations management, process optimization, and strategic development. At Stryker, he has been instrumental in enhancing the company’s operational efficiencies, supply chain management, and overall business strategies. His leadership style is often characterized by a strong focus on fostering innovation, improving customer satisfaction, and driving sustainable growth. Menon's contributions have been vital in maintaining Stryker's position as a leader in the medical technology sector.
Mr. J. Andrew Pierce
Group President of MedSurg & Neurotechnology
J. Andrew Pierce is a notable figure associated with Stryker Corporation, a leading medical technology company. As of the latest information available, he serves as the Group President of MedSurg and Neurotechnology at Stryker. In this capacity, he oversees Stryker's operations related to its MedSurg and Neurotechnology business segments, focusing on driving innovation and growth within these areas.
Pierce joined Stryker in 1990 and has held various leadership roles throughout his career, demonstrating strong expertise and a significant impact on the company's development. His leadership skills and strategic vision have been instrumental in expanding Stryker's market presence and enhancing its product offerings.
Under his guidance, the MedSurg and Neurotechnology divisions have achieved substantial progress, contributing to Stryker's overall success as a prominent player in the medical technology industry. Pierce’s commitment to innovation, quality, and customer satisfaction underscores his effectiveness as a leader at Stryker.
Mr. Spencer S. Stiles
Group President of Orthopaedics & Spine
Spencer S. Stiles is an executive at Stryker Corp., a leading medical technologies firm. He has held various leadership roles within the company. Currently, he serves as the Group President of Orthopaedics and Spine, overseeing the strategic direction and operation of these divisions. Stiles joined Stryker in 1996 and has held numerous positions, gaining extensive experience across different business units. His leadership has been instrumental in driving growth and innovation within the organization. Stiles is known for his strong focus on operational excellence and delivering value to both the company and its customers.
Mr. William E. Berry Jr.
VP & Chief Accounting Officer
William E. Berry Jr. is a well-regarded business executive who served as the Vice President, Corporate Secretary, and Chief Legal Officer of Stryker Corporation. In his role at Stryker, a leading medical technologies firm, Berry was responsible for overseeing the legal affairs of the company, including corporate governance and compliance matters. His expertise in legal management and dedication to ensuring ethical practices were key in maintaining Stryker’s reputable standing in the healthcare sector.
Berry's extensive legal background, combined with his experience in corporate governance, positioned him as a valuable leader within the company. His work contributed significantly to navigating the complex regulatory environment of the medical device industry. Berry's leadership and strategic insight were instrumental in steering the company's growth and success in deploying advanced medical technologies worldwide.
Mr. Robert C. Cohen
CTO and VP of Global R&D - Joint Replacement
Robert C. Cohen is a prominent executive known for his leadership at Stryker Corporation, a global leader in medical technology. At Stryker, he has held significant roles, especially within the company's Orthopaedics division. As President of Stryker's Digital, Robotics, and Enabling Technologies group, Cohen played a key role in advancing the company's innovative solutions, focusing on robotics and digital advancements that align with the future of orthopedic surgeries.
Under his leadership, Stryker has seen developments in robotic-assisted surgery with their Mako system, as well as other digital technology mergers that have bolstered the company's presence in the medical tech industry. Robert Cohen is recognized for his capacity to drive growth, his strategic vision, and his commitment to improving patient outcomes through cutting-edge technology. His deep industry experience and forward-thinking approach continue to propel Stryker's mission of making healthcare better.
Mr. Alan Douville
VP, Chief Information Officer & Chief Information Security Officer
As of the last available information, Alan Douville served as an executive at Stryker Corporation. Stryker is a well-known medical technologies firm, and executives play crucial roles in overseeing its operations and strategic direction. Their leadership is essential in shaping the company's innovations in medical devices and equipment, which contributes to advancements in healthcare. However, specific details about Alan Douville’s role, accomplishments, or biography at Stryker Corp are not readily available publicly. Therefore, detailed personal or career-related information about him might be limited to internal company resources or private documents. If you are seeking specific details, it would be beneficial to consult Stryker's official resources or press releases.
Mr. Jason Beach
Vice President of Finance & Investor Relations
Jason Beach is not widely recognized in public directories or notable executive profiles associated with Stryker Corporation, a prominent medical technology company. Without specific information or verified sources, it is challenging to provide a detailed biography for an executive by that name from Stryker Corp. If you have more context or specific details about his role or contributions, it might help refine the search. Otherwise, based on the available data, I would conclude "FALSE" regarding any widely acknowledged biography of Jason Beach at Stryker Corporation.
Mr. Robert S. Fletcher
VP & Chief Legal Officer
Robert S. Fletcher is an executive known for his leadership role at Stryker Corporation, a leading medical technologies firm. At Stryker, Fletcher has been instrumental in driving the company's strategic initiatives, focusing on innovation and growth across its diverse product lines. Under his leadership, Stryker has advanced in areas such as orthopedics, medical and surgical equipment, and neurotechnology.
Fletcher has a strong background in the healthcare and medical devices industry, bringing with him a wealth of experience that supports the company's mission to make health care better. He is recognized for his ability to align Stryker's operations with global health care demands, ensuring the organization remains at the forefront of technological advancement and patient care enhancement.
His tenure at Stryker is marked by a commitment to quality and a forward-thinking approach to addressing the needs of health care professionals and patients worldwide. Through fostering innovation, improving operational efficiencies, and managing a dynamic portfolio, Fletcher continues to contribute significantly to Stryker’s prominence in the global market.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.